Inventiva S.A. American Depository Shares (IVA)
IVA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1756594/000110465925035122/0001104659-25-035122-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2024-12-31. Converted from EUR at 0.8933 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | IVA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | France |
| IPO year | 2020 |
| SEC CIK | 0001756594 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | I0 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $10.3M |
| Net income | -$206.2M |
| Operating income | Not in SEC XBRL data |
| Net margin | -2002.7% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 65.9× |
Reported in EUR; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-02 |
| Latest annual report | 20-F | 2026-04-08 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-06 |
Source: SEC EDGAR submissions feed, 227 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -13.5% |
| 1 month | -24.6% |
| 3 months | -35.6% |
| Year to date | -37.4% |
| 1 year | -36.9% |
| From 52-week high | -59.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| VSTM | Verastem Inc. | $7.45 | -9.70% | $674.7M |
| PHAR | Pharming Group N.V. ADS each representing 10 | $9.44 | -1.77% | $666.7M |
| COLL | Collegium Pharmaceutical Inc. | $21.53 | -2.36% | $700.9M |
| AVTX | Avalo Therapeutics Inc. | $12.01 | -9.29% | $644.1M |
| LXRX | Lexicon Pharmaceuticals Inc. | $1.61 | -2.42% | $716.4M |
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
| ABUS | Arbutus Biopharma Corporation | $4.11 | -0.96% | $630.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier